The effect of menaquinone-7 supplementation on dp-ucMGP, PIVKAII, inflammatory markers, and body composition in type 2 diabetes patients: a randomized clinical trial.
Nahid KaramzadEsmaeil FarajiShaghayegh AdeliMark J M SullmanBahram Pourghassem GargariPublished in: Nutrition & diabetes (2022)
This study was prospectively registered at the Iranian Registry of Clinical Trials on the 20th of May 2019 (ID: IRCT20100123003140N22).
Keyphrases
- body composition
- type diabetes
- clinical trial
- end stage renal disease
- resistance training
- newly diagnosed
- ejection fraction
- chronic kidney disease
- bone mineral density
- peritoneal dialysis
- prognostic factors
- cardiovascular disease
- randomized controlled trial
- adipose tissue
- insulin resistance
- high intensity
- patient reported